# Zoetis Belgium S.A. – FDA 483, Jan 16, 2026

Source: https://www.keypedia.com/records/483/zoetis-belgium-sa/a5eb534e-a49b-478d-bd45-857029296948

> FDA 483 for Zoetis Belgium S.A. on January 16, 2026. Product: drugs. Access full analysis and detailed observations.

---

## Details

- Record Type: 483
- Company Name: Zoetis Belgium S.A.
- Inspection Date: 2026-01-16
- Product Type: drugs
- Office Name: Office of Inspections and Investigations
- Summary: Zoetis Belgium S.A., an API manufacturer in Wicklow, Ireland, was cited for significant deficiencies in laboratory controls, equipment cleaning, computer system controls, and reserve sample management. The inspection revealed failures to follow established procedures, lack of critical testing, and inadequate data integrity measures, indicating a moderate level of severity regarding GMP compliance.

## Related Documents

- [483 - 2022-03-25](https://www.keypedia.com/records/483/zoetis-belgium-sa/ba8eb29c-6c20-4bad-bd4d-e339a59370c3) — date: March 25, 2022

## Related Officers

- [Bijoy Panicker](https://www.keypedia.com/people/bijoy-panicker/1c6ec57f-e02e-49b8-8b59-1853f3d2947a)

Company: https://www.keypedia.com/companies/zoetis-belgium-sa/d938ee23-71b2-48af-ab3f-ad520750d043

Office: https://www.keypedia.com/offices/office-of-inspections-and-investigations/7dd0b904-a3df-46bc-a7b2-70ddb6f809c8